Small EJ - Search Results

1

Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

Small EJ, Halabi S, Dawson NA, Stadler WM, Rini BI, Picus J, Gable P, Torti FM, Kaplan E, Vogelzang NJ. Small EJ, et al. J Clin Oncol. 2004 Mar 15;22(6):1025-33. doi: 10.1200/JCO.2004.06.037. J Clin Oncol. 2004. PMID: 15020604 Clinical Trial.

2

Prostate cancer: who to screen, and what the results mean.

Small EJ. Small EJ. Geriatrics. 1993 Dec;48(12):28-30, 35-8. Geriatrics. 1993. PMID: 7504646 Review.

3

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.

Small EJ, Carroll PR. Small EJ, et al. Urology. 1994 Mar;43(3):408-10. doi: 10.1016/0090-4295(94)90092-2. Urology. 1994. PMID: 7510915

4

Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy.

Timmerman JM, Northfelt DW, Small EJ. Timmerman JM, et al. Among authors: small ej. J Clin Oncol. 1995 Jun;13(6):1391-7. doi: 10.1200/JCO.1995.13.6.1391. J Clin Oncol. 1995. PMID: 7538557

5

The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.

Small EJ, Srinivas S. Small EJ, et al. Cancer. 1995 Oct 15;76(8):1428-34. doi: 10.1002/1097-0142(19951015)76:8<1428::aid-cncr2820760820>3.0.co;2-t. Cancer. 1995. PMID: 8620419

6

Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer.

Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP. Small EJ, et al. J Clin Oncol. 1996 May;14(5):1617-25. doi: 10.1200/JCO.1996.14.5.1617. J Clin Oncol. 1996. PMID: 8622080 Clinical Trial.

7

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.

Small EJ, Vogelzang NJ. Small EJ, et al. J Clin Oncol. 1997 Jan;15(1):382-8. doi: 10.1200/JCO.1997.15.1.382. J Clin Oncol. 1997. PMID: 8996165 Review.

8

Cancer and Leukemia Group B trials for advanced prostate cancer.

Small EJ, Dawson NA, Kantoff PW, Vogelzang NJ. Small EJ, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):28-31. Semin Oncol. 1996. PMID: 8996582 Review.

9

Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal.

Small EJ, Baron AD, Fippin L, Apodaca D. Small EJ, et al. J Urol. 1997 Apr;157(4):1204-7. J Urol. 1997. PMID: 9120902 Clinical Trial.

10

Focal therapy for prostate cancer 1996: maximizing outcome.

Carroll PR, Presti JC Jr, Small E, Roach M 3rd. Carroll PR, et al. Urology. 1997 Mar;49(3A Suppl):84-94. doi: 10.1016/s0090-4295(97)00174-x. Urology. 1997. PMID: 9123742 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters